We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Eye-Drug Compounder Can't Dodge Allergan Suit

Law360, New York (November 15, 2017, 9:16 PM EST) -- A California federal judge on Tuesday kept alive Allergan’s false advertising suit against a large drug compounder, saying there are sufficient allegations the compounder is manufacturing eye medicines without adhering to...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


California Central

Nature of Suit

890(Other Statutory Actions)


Subscribers Only

Date Filed

September 7, 2017

Law Firms


Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.